We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleOral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.AuthorsSchimrigk S; Brune N; Hellwig K; Lukas C; Bellenberg B; Rieks M; Hoffmann V; Pöhlau D; Przuntek HPublicationEuropean journal of neurology, 2006, Vol 13, Issue 6, p604ISSN1351-5101Publication typearticleDOI10.1111/j.1468-1331.2006.01292.x